These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13066702)

  • 21. [Variability of in vitro activity of proguanil and cycloguanil on erythrocyte stages of Plasmodium falciparum as a function of culture conditions].
    Ndounga M; Basco LK; Ringwald P
    Bull Soc Pathol Exot; 1999 Dec; 92(5):313-6. PubMed ID: 10690466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark.
    Brøsen K; Skjelbo E; Flachs H
    Br J Clin Pharmacol; 1993 Aug; 36(2):105-8. PubMed ID: 8398577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition by omeprazole of proguanil metabolism: mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments.
    Funck-Brentano C; Becquemont L; Lenevu A; Roux A; Jaillon P; Beaune P
    J Pharmacol Exp Ther; 1997 Feb; 280(2):730-8. PubMed ID: 9023285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of S-mephenytoin hydroxylase (CYP2C19) in the metabolism of the antimalarial biguanides.
    Wright JD; Helsby NA; Ward SA
    Br J Clin Pharmacol; 1995 Apr; 39(4):441-4. PubMed ID: 7640152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Color reaction of chlorhexidine and proguanil with hypobromite].
    Görlitzer K; Huth S; Jones PG
    Pharmazie; 2005 Apr; 60(4):269-72. PubMed ID: 15881606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.
    Ward SA; Watkins WM; Mberu E; Saunders JE; Koech DK; Gilles HM; Howells RE; Breckenridge AM
    Br J Clin Pharmacol; 1989 Jun; 27(6):781-7. PubMed ID: 2757894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experiments with antimalarial drugs in man. III. Experiments with compound 5943.
    ROBERTSON GI
    Trans R Soc Trop Med Hyg; 1957 Sep; 51(5):457-62. PubMed ID: 13468007
    [No Abstract]   [Full Text] [Related]  

  • 29. Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.
    Edstein MD; Kotecka BM; Anderson KL; Pombo DJ; Kyle DE; Rieckmann KH; Good MF
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4421-2. PubMed ID: 16189139
    [No Abstract]   [Full Text] [Related]  

  • 30. Malaria prophylaxis with proguanil and sulfisoxazole in children living in a malaria endemic area.
    Pang LW; Limsomwong N; Singharaj P; Canfield CJ
    Bull World Health Organ; 1989; 67(1):51-8. PubMed ID: 2706727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmics. VII. Quinidine-like activity of proguanil, supazine and daraprim.
    ARORA RB; MADAN BR
    Indian J Med Res; 1956 Jul; 44(3):449-52. PubMed ID: 13366418
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmaceutical care for international voyagers: prophylaxis including chloroquine plus proguanil].
    Hernández Tintorer JL; Lorduy Osés L
    Farm Hosp; 2004; 28(2):137-40. PubMed ID: 15101806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL
    J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil].
    Pradines B; Mabika Mamfoumbi M; Keundjian A; Lebeau C; Fusai T; Owono Medang M; Rogier C; Parzy D; Kombila M
    Bull Soc Pathol Exot; 1999 May; 92(2):91-4. PubMed ID: 10399596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimalarial drugs in West Africa, with particular reference to proguanil; results of a survey in Nigeria.
    BRUCE-CHWATT LJ; BRUCE-CHWATT JM
    Br Med J; 1950 Jul; 2(4669):7-14. PubMed ID: 15426791
    [No Abstract]   [Full Text] [Related]  

  • 37. Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians.
    Skjelbo E; Mutabingwa TK; Bygbjerg Ib; Nielsen KK; Gram LF; Brøosen K
    Clin Pharmacol Ther; 1996 Mar; 59(3):304-11. PubMed ID: 8653993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate.
    Gupta RK; Van Vugt M; Paiphun L; Slight T; Looareesuwan S; White NJ; Nosten F
    Am J Trop Med Hyg; 2005 Aug; 73(2):267-8. PubMed ID: 16103586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superior antimalarial activity of proguanil to cycloguanil after in vitro bioconversion.
    Ramanaiah TV; Gajanana A
    Trans R Soc Trop Med Hyg; 1988; 82(3):358-9. PubMed ID: 3068842
    [No Abstract]   [Full Text] [Related]  

  • 40. Bullous erythema multiforme after treatment with Malarone, a combination antimalarial composed of atovaquone and proguanil hydrochloride.
    Remich SA; Otieno W; Polhemus ME; Ogutu B; Walsh DS
    Trop Doct; 2008 Jul; 38(3):190-1. PubMed ID: 18628561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.